Find your path to Ansbert
58 people in our graph share verified history with Ansbert — schools, employers, funds. One of them is your warm intro.
About
Managing Partner and founder of MPM Capital in 1992 as a biotech venture capital firm. Led investments in major successes including BioMarin Pharmaceuticals, Pharmasset (acquired by Gilead), and Cullinan Therapeutics. Recipient of 2017 Global Oncology Visionary Award.
Contact· self-published, not guessed
Experience
- MPM BioImpactManaging Partnercurrent1992 — present
Deals · 5
Reunion NeuroscienceBoard seat
via MPM BioImpact · filed Sep 2025 · $119.8M raise
Orna Therapeutics Holdings, LLCBoard seat
via MPM BioImpact · filed Aug 2022
iTeos TherapeuticsBoard seat
via MPM BioImpact · filed Mar 2020
ViraCyteBoard seat
via MPM BioImpact · filed Sep 2018
ChiasmaBoard seat
via MPM BioImpact · filed Mar 2015 · $87.2M raise
Attribution from SEC filings, press coverage, and firm rosters.
Other disclosed investments
Board seats
Investor
elevatebioElixir PharmaceuticalsK2 TherapeuticsOrnaPharmAtheneRadius HealthRaze TherapeuticsReNAgade TherapeuticsSideris PharmaceuticalsTCR2Verastem Oncology
Sources: SEC Form D filings · curated public sources.
Colleagues at MPM BioImpact
Network8
Investors connected to Ansbert in public investor directories — a warm-intro map.
Frequently asked questions
- Who is Ansbert K. Gadicke?
- Managing Partner and founder of MPM Capital in 1992 as a biotech venture capital firm. Led investments in major successes including BioMarin Pharmaceuticals, Pharmasset (acquired by Gilead), and Cullinan Therapeutics. Recipient of 2017 Global Oncology Visionary Award.
- Where does Ansbert K. Gadicke work?
- Ansbert K. Gadicke is Managing Partner at MPM BioImpact.
- What boards does Ansbert K. Gadicke sit on?
- Ansbert K. Gadicke holds tracked board seats at Chiasma, Clinical ink, iTeos Therapeutics, NextPoint Therapeutics, Orna Therapeutics Holdings, LLC, Reunion Neuroscience, ViraCyte.
- What companies has Ansbert K. Gadicke invested in?
- Investments tracked here include Chiasma, elevatebio, Elixir Pharmaceuticals, iTeos Therapeutics, K2 Therapeutics, Orna, PharmAthene, Radius Health, Raze Therapeutics, ReNAgade Therapeutics, Reunion Neuroscience, Sideris Pharmaceuticals, and 2 more.